Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 4/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 4/20 | 1.00 |
| ▸ | PGAM1 | P18669 | 6/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | MAOA | P21397 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.63 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | TTR | P02766 | 1/20 | 0.63 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384381 | 1.00 | BCL2 (1.00) | BCL2MCL1PGAM1MAPTMEN1 | |
| SCHEMBL29388375 | 1.00 | BCL2 (1.00) | BCL2MCL1PGAM1MAPTMEN1 | |
| Methoxymethane SCHEMBL9852502 | 0.93 | BCL2 (0.86) | BCL2MCL1PGAM1MAPTMEN1 | |
| SCHEMBL31017308 | 0.87 | BCL2 (0.76) | BCL2MCL1PGAM1MAPTMEN1 | |
| SCHEMBL29665051 | 0.87 | BCL2 (0.76) | BCL2MCL1PGAM1MAPTMEN1 | |
| SCHEMBL1230309 | 0.87 | BCL2 (0.76) | BCL2MCL1PGAM1MAPTMEN1 | |
| SCHEMBL3937902 | 0.87 | BCL2 (0.77) | BCL2MCL1PGAM1MAPTMEN1 | |
| SCHEMBL3182318 | 0.85 | BCL2 (0.73) | BCL2MCL1MAPTMEN1MAOA | |
| SCHEMBL3174840 | 0.83 | BCL2 (0.71) | BCL2MCL1PGAM1MAPTMEN1 | |
| Rubiadin SCHEMBL22616292 | 0.83 | BCL2 (0.71) | BCL2MCL1PGAM1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 751 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240204171-A1 | ELECTRODE COMPRISING CARBON NANOTUBES AND AROMATIC COMPOUNDS AND PROCESS OF PREPARATION THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-06-20 | — | — | US | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-115537013-B | Nuclear radiation resistant polyurethane elastomer material and preparation method thereof | 中国人民解放军海军工程大学 | 2024-03-29 | — | — | CN | claimed |
| EP-4288384-A1 | A NONCOVALENT HYBRID COMPRISING CARBON NANOTUBES (CNT) AND AROMATIC COMPOUNDS AND USES THEREOF | Yeda Research and Development Co. Ltd (IL) | 2023-12-13 | — | — | EP | claimed |
| CN-116802149-A | Non-covalent hybrids comprising Carbon Nanotubes (CNTs) and aromatic compounds and uses thereof | 耶达研究与发展有限公司 | 2023-09-22 | — | — | CN | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-115537013-A | Nuclear radiation resistant polyurethane elastomer material and preparation method thereof | 中国人民解放军海军工程大学 | 2022-12-30 | — | — | CN | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-1065672-A | The high-temperature adhesives composition | LORD CORP (US) | 1992-10-28 | — | — | CN | claimed |
| EP-0508650-A2 | High-temperature adhesive compositions | LORD CORPORATION (US) | 1992-10-14 | — | — | EP | claimed |
| US-5128403-A | A mixture of perhalocyclic diene-modified polyconjugated diene, phenolic resin, a phenol, an aldehyde, thermosensitive elastomer crosslinker, vulcanizer and metal oxide; bonding metal and elastomer; heat resistance | LORD CORPORATION (US) | 1992-07-07 | — | — | US | claimed |
| CN-1060101-A | Phenolic resin adhesion promoters and binder composition | LORD CORP (US) | 1992-04-08 | — | — | CN | claimed |
| EP-0476902-A2 | Phenolic resin adhesion promoters and adhesive compositions | LORD CORPORATION (US) | 1992-03-25 | — | — | EP | claimed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| US-4885244-A | CONTACTING MICROORGANISM WITH SACCHARIDE IN POLYHYDRIC AROMATIC COMPOUND CONTAINING MEDIUM; HIGH MOLECULAR WEIGHT | MITSUBISHI RAYON CO., LTD. (JP) | 1989-12-05 | — | — | US | claimed |
| US-4425404-A | MULTILAYER, PROTECTIVE COATINGS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| US-4181545-A | POT LIFE OF HYDROXY POLYBUTADIENE | UNITED TECHNOLOGIES CORPORATION (US) | 1980-01-01 | — | — | US | claimed |
| US-4109051-A | POLYHYDROXY AROMATIC COATING COMPOSITIONS FOR REINFORCING GLASS FIBERS USED IN CEMENTITIOUS PRODUCTS | PILKINGTON BROTHERS LIMITED (GB) | 1978-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | BCL2 646/4885MCL1 2223/4885PGAM1 3488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.